People
Nathanael Gray, PhD
Nathanael Gray received his PhD in chemistry from the University of California at Berkeley in 1999. He then moved to the Genomics Institute of the Novartis Research Foundation in San Diego, where after serving as a staff scientist and group leader of kinase inhibitor chemistry, he was named director of biological chemistry in 2001. Dr. Gray joined the faculty of Harvard Medical School and DFCI in 2006 to continue his research using synthetic chemistry and functional small molecule discovery to modulate biological pathways important in cancer.
Gray lab website, with a list of recent publications.
Nathanael Gray received his PhD in chemistry from the University of California at Berkeley in 1999. He then moved to the Genomics Institute of the Novartis Research Foundation in San Diego, where after serving as a staff scientist and group leader of kinase inhibitor chemistry, he was named director of biological chemistry in 2001. Dr. Gray joined the faculty of Harvard Medical School and DFCI in 2006 to continue his research using synthetic chemistry and functional small molecule discovery to modulate biological pathways important in cancer.
Gray lab website, with a list of recent publications.
David Scott, PhD
David Scott received his PhD in Organic Chemistry from the University of Oxford, prior to working as a post-doc at UT Austin. He spent ten years as a medicinal chemist in AstraZeneca's Oncology research group, where he helped advance several small molecule drug discovery projects towards the clinic. Dr Scott joined the core in 2014.
David Scott received his PhD in Organic Chemistry from the University of Oxford, prior to working as a post-doc at UT Austin. He spent ten years as a medicinal chemist in AstraZeneca's Oncology research group, where he helped advance several small molecule drug discovery projects towards the clinic. Dr Scott joined the core in 2014.
John Hatcher, PhD
John Hatcher received his PhD in Organic Chemistry from Duke University in 2011, and then worked as a post-doc in Nathanael Gray's lab, developing small molecule kinase inhibitors. He was recently promoted to Research Scientist, and continues to develop kinase and cysteine protease inhibitors.
John Hatcher received his PhD in Organic Chemistry from Duke University in 2011, and then worked as a post-doc in Nathanael Gray's lab, developing small molecule kinase inhibitors. He was recently promoted to Research Scientist, and continues to develop kinase and cysteine protease inhibitors.